跳至主要内容
临床试验/NCT04136080
NCT04136080Unknown不适用

The Effect of Increasing the Mean Arterial Pressure on the Microcirculation and the Prognosis of Patients With Septic Shock

Fujian Provincial Hospital0 个研究点目标入组 752 人开始时间: 2019年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
752
主要终点
the 28-day all-cause mortality and Changes of sublingual microcirculation

研究概览

简要总结

Background: The mean arterial pressure( MAP) is a key pressure index to improve tissue perfusion. At present, there are no surprising results of large-scale clinical studies on sublingual microcirculation. The changes of sublingual microcirculation were more severe in septic shock non-survivors than survivors. Purpose: This study is mean to increase the MAP in septic shock patients whether with chronic hypertension or not, so as to observe the change of the microcirculation and prognosis. Method: This is a single-center, randomized, prospective cohort study. Eligible patients will be allocated into chronic hypertension or denying chronic hypertension group. These patients will be treat with vasopressors to maintain MAP at 90±5 mmHg and 70±5 mmHg. Outcome: The 28-day all-cause mortality, the 90-day all-cause mortality, the 28-day without organ dysfunction days, the Changes of sublingual microcirculation, SOFA, APACHE-Ⅱ score Will be recorded.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Adult patients (≥18 years) admitted to The Critical Medicine Departments Three of Fujian Provincial Hospital will be considered eligible,who are presence of infection or suspected infection,requiring mechanical ventilation. At the same time, without the vasopressors the MAP would be less than 65mmHg, and the blood lactic acid level is higher than 2mmol/l.

排除标准

  • 未提供

研究组 & 干预措施

chronic hypertension group

Other

septic patients with chronic hypertension

干预措施: vasopressors (Other)

denying chronic hypertension group

Other

septic patients without chronic hypertension

干预措施: vasopressors (Other)

结局指标

主要结局

the 28-day all-cause mortality and Changes of sublingual microcirculation

时间窗: 28 day

the 28-day all-cause mortality and Changes of sublingual microcirculation

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Xiuling Shang

Senior physician

Fujian Provincial Hospital

相似试验